Interaction between hypertension and cerebral hypoperfusion in the development of cognitive dysfunction and white matter pathology in rats

Neuroscience

Volumn 303, Issue , 2015, Pages 115-125

  Choi, J Y ^a   Cui, Y ^a   Kim, B G ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Blood brain barrier; Hypertension; Myelination; Node of ranvier; White matter stroke

Indexed keywords

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD PRESSURE; BRAIN ISCHEMIA; CELL COUNT; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMYELINATION; DISEASE SEVERITY; EXPERIMENTAL BEHAVIORAL TEST; HYPERTENSION; MALE; MEMORY DISORDER; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; PARANODAL STRUCTURE; PRIORITY JOURNAL; RANVIER NODE; RAT; SPATIAL MEMORY; WHITE MATTER; WHITE MATTER INJURY; ANIMAL; BRAIN CORTEX; COMPLICATION; DEMENTIA, VASCULAR; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RECOGNITION; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULARIZATION; WISTAR RAT;

ANIMALS; BLOOD-BRAIN BARRIER; CEREBRAL CORTEX; DEMENTIA, VASCULAR; HYPERTENSION; MALE; RANVIER'S NODES; RATS; RATS, INBRED SHR; RATS, WISTAR; RECOGNITION (PSYCHOLOGY); SPATIAL MEMORY; WHITE MATTER;

EID: 84936858338     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.06.056     Document Type: Article

References (41)

1. Al-Sarraf H., Philip L. Effect of hypertension on the integrity of blood brain and blood CSF barriers, cerebral blood flow and CSF secretion in the rat. Brain Res 2003, 975:179-188.
2. Arai K., Lo E.H. An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells. J Neurosci 2009, 29:4351-4355.
3. Arancibia-Carcamo I.L., Attwell D. The node of Ranvier in CNS pathology. Acta Neuropathol 2014, 128:161-175.
4. Bhat M.A., Rios J.C., Lu Y., Garcia-Fresco G.P., Ching W., St Martin M., Li J., Einheber S., Chesler M., Rosenbluth J., Salzer J.L., Bellen H.J. Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV/Caspr/paranodin. Neuron 2001, 30:369-383.
5. Calcinaghi N., Wyss M.T., Jolivet R., Singh A., Keller A.L., Winnik S., Fritschy J.M., Buck A., Matter C.M., Weber B. Multimodal imaging in rats reveals impaired neurovascular coupling in sustained hypertension. Stroke 2013, 44:1957-1964.
6. Coltman R., Spain A., Tsenkina Y., Fowler J.H., Smith J., Scullion G., Allerhand M., Scott F., Kalaria R.N., Ihara M., Daumas S., Deary I.J., Wood E., McCulloch J., Horsburgh K. Selective white matter pathology induces a specific impairment in spatial working memory. Neurobiol Aging 2011, 32(2324):e2327-2312.
7. de Groot J.C., de Leeuw F.E., Oudkerk M., van Gijn J., Hofman A., Jolles J., Breteler M.M. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000, 47:145-151.
8. De Reuck J., Crevits L., De Coster W., Sieben G., vander Eecken H. Pathogenesis of Binswanger chronic progressive subcortical encephalopathy. Neurology 1980, 30:920-928.
9. D'Hooge R., De Deyn P.P. Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 2001, 36:60-90.
10. Farkas E., Donka G., de Vos R.A., Mihaly A., Bari F., Luiten P.G. Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain. Acta Neuropathol 2004, 108:57-64.
11. Farkas E., Luiten P.G., Bari F. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev 2007, 54:162-180.
12. Gorelick P.B., Scuteri A., Black S.E., Decarli C., Greenberg S.M., Iadecola C., Launer L.J., Laurent S., Lopez O.L., Nyenhuis D., Petersen R.C., Schneider J.A., Tzourio C., Arnett D.K., Bennett D.A., Chui H.C., Higashida R.T., Lindquist R., Nilsson P.M., Roman G.C., Sellke F.W., Seshadri S. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 2011, 42:2672-2713.
13. Hughes R.N. The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neurosci Biobehav Rev 2004, 28:497-505.
14. Jalal F.Y., Yang Y., Thompson J., Lopez A.C., Rosenberg G.A. Myelin loss associated with neuroinflammation in hypertensive rats. Stroke 2012, 43:1115-1122.
15. Jiwa N.S., Garrard P., Hainsworth A.H. Experimental models of vascular dementia and vascular cognitive impairment: a systematic review. J Neurochem 2010, 115:814-828.
16. Lindsay J., Hebert R., Rockwood K. The Canadian Study of Health and Aging: risk factors for vascular dementia. Stroke 1997, 28:526-530.
17. Liu H.X., Zhang J.J., Zheng P., Zhang Y. Altered expression of MAP-2, GAP-43, and synaptophysin in the hippocampus of rats with chronic cerebral hypoperfusion correlates with cognitive impairment. Brain Res Mol Brain Res 2005, 139:169-177.
18. Masumura M., Hata R., Nagai Y., Sawada T. Oligodendroglial cell death with DNA fragmentation in the white matter under chronic cerebral hypoperfusion: comparison between normotensive and spontaneously hypertensive rats. Neurosci Res 2001, 39:401-412.
19. Matsuo A., Lee G.C., Terai K., Takami K., Hickey W.F., McGeer E.G., McGeer P.L. Unmasking of an unusual myelin basic protein epitope during the process of myelin degeneration in humans: a potential mechanism for the generation of autoantigens. Am J Pathol 1997, 150:1253-1266.
20. Mueller S.M., Heistad D.D. Effect of chronic hypertension on the blood-brain barrier. Hypertension 1980, 2:809-812.
21. Nordborg C., Johansson B.B. Morphometric study on cerebral vessels in spontaneously hypertensive rats. Stroke 1980, 11:266-270.
22. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010, 9:689-701.
23. Paschen W., Mies G., Bodsch W., Yamori Y., Hossmann K.A. Regional cerebral blood flow, glucose metabolism, protein synthesis, serum protein extravasation, and content of biochemical substrates in stroke-prone spontaneously hypertensive rats. Stroke 1985, 16:841-845.
24. Pedraza L., Huang J.K., Colman D.R. Organizing principles of the axoglial apparatus. Neuron 2001, 30:335-344.
25. Peila R., White L.R., Masaki K., Petrovitch H., Launer L.J. Reducing the risk of dementia: efficacy of long-term treatment of hypertension. Stroke 2006, 37:1165-1170.
26. Pires P.W., Dams Ramos C.M., Matin N., Dorrance A.M. The effects of hypertension on the cerebral circulation. Am J Physiol Heart Circ Physiol 2013, 304:H1598-1614.
27. Reimer M.M., McQueen J., Searcy L., Scullion G., Zonta B., Desmazieres A., Holland P.R., Smith J., Gliddon C., Wood E.R., Herzyk P., Brophy P.J., McCulloch J., Horsburgh K. Rapid disruption of axon-glial integrity in response to mild cerebral hypoperfusion. J Neurosci 2011, 31:18185-18194.
28. Ritter J., Schmitz T., Chew L.J., Buhrer C., Mobius W., Zonouzi M., Gallo V. Neonatal hyperoxia exposure disrupts axon-oligodendrocyte integrity in the subcortical white matter. J Neurosci 2013, 33:8990-9002.
29. Sabbatini M., Strocchi P., Vitaioli L., Amenta F. Microanatomical changes of intracerebral arteries in spontaneously hypertensive rats: a model of cerebrovascular disease of the elderly. Mech Ageing Dev 2001, 122:1257-1268.
30. Sarti C., Pantoni L., Bartolini L., Inzitari D. Cognitive impairment and chronic cerebral hypoperfusion: what can be learned from experimental models. J Neurol Sci 2002, 203-204:263-266.
31. Sayan-Ozacmak H., Ozacmak V.H., Barut F., Jakubowska-Dogru E. Neuroprotective efficacy of the peroxisome proliferator-activated receptor-gamma ligand in chronic cerebral hypoperfusion. Curr Neurovasc Res 2011, 8:190-199.
32. Schmidt R., Petrovic K., Ropele S., Enzinger C., Fazekas F. Progression of leukoaraiosis and cognition. Stroke 2007, 38:2619-2625.
33. Shang Y., Cheng J., Qi J., Miao H. Scutellaria flavonoid reduced memory dysfunction and neuronal injury caused by permanent global ischemia in rats. Pharmacol Biochem Behav 2005, 82:67-73.
34. Sonnen J.A., Larson E.B., Crane P.K., Haneuse S., Li G., Schellenberg G.D., Craft S., Leverenz J.B., Montine T.J. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 2007, 62:406-413.
35. Thaxton C., Bhat M.A. Myelination and regional domain differentiation of the axon. Results Probl Cell Differ 2009, 48:1-28.
36. Toledo J.B., Arnold S.E., Raible K., Brettschneider J., Xie S.X., Grossman M., Monsell S.E., Kukull W.A., Trojanowski J.Q. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. Brain 2013, 136:2697-2706.
37. Vicente E., Degerone D., Bohn L., Scornavaca F., Pimentel A., Leite M.C., Swarowsky A., Rodrigues L., Nardin P., de Almeida L.M., Gottfried C., Souza D.O., Netto C.A., Goncalves C.A. Astroglial and cognitive effects of chronic cerebral hypoperfusion in the rat. Brain Res 2009, 1251:204-212.
38. Wakita H., Tomimoto H., Akiguchi I., Matsuo A., Lin J.X., Ihara M., McGeer P.L. Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res 2002, 924:63-70.
39. Wardlaw J.M., Sandercock P.A., Dennis M.S., Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?. Stroke 2003, 34:806-812.
40. Whishaw I.Q., Jarrard L.E. Similarities vs. differences in place learning and circadian activity in rats after fimbria-fornix section or ibotenate removal of hippocampal cells. Hippocampus 1995, 5:595-604.
41. Wu X., Tolvanen J.P., Hutri-Kahonen N., Kahonen M., Makynen H., Korpela R., Ruskoaho H., Karjala K., Porsti I. Comparison of the effects of supplementation with whey mineral and potassium on arterial tone in experimental hypertension. Cardiovasc Res 1998, 40:364-374.